Emergent BioSolutions (NYSE: EBS)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Emergent BioSolutions (NYSE: EBS) through any online brokerage.
The latest price target for Emergent BioSolutions (NYSE: EBS) was reported by Wells Fargo on Wednesday, May 4, 2022. The analyst firm set a price target for 38.00 expecting EBS to rise to within 12 months (a possible 19.50% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Emergent BioSolutions (NYSE: EBS) is $31.8 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Emergent BioSolutions.
Emergent BioSolutions’s Q2 earnings are confirmed for Thursday, July 28, 2022.
There is no upcoming split for Emergent BioSolutions.
Emergent BioSolutions is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.